247 related articles for article (PubMed ID: 28408291)
41. [Chronic Activation of the Dopaminergic Neuronal Pathway Improves Behavioral Abnormalities in the Prenatal Valproic Acid Exposure Mouse Model of Autism Spectrum Disorder].
Hara Y
Yakugaku Zasshi; 2019; 139(11):1391-1396. PubMed ID: 31685735
[TBL] [Abstract][Full Text] [Related]
42. Developmental and behavioral alterations in zebrafish embryonically exposed to valproic acid (VPA): An aquatic model for autism.
Chen J; Lei L; Tian L; Hou F; Roper C; Ge X; Zhao Y; Chen Y; Dong Q; Tanguay RL; Huang C
Neurotoxicol Teratol; 2018; 66():8-16. PubMed ID: 29309833
[TBL] [Abstract][Full Text] [Related]
43. Micromolar Valproic Acid Doses Preserve Survival and Induce Molecular Alterations in Neurodevelopmental Genes in Two Strains of Zebrafish Larvae.
Messina A; Boiti A; Sovrano VA; Sgadò P
Biomolecules; 2020 Sep; 10(10):. PubMed ID: 32987891
[TBL] [Abstract][Full Text] [Related]
44. Altered expression of glycan patterns and glycan-related genes in the medial prefrontal cortex of the valproic acid rat model of autism.
Liu Y; Di Y; Zheng Q; Qian Z; Fan J; Ren W; Wei Z; Tian Y
Front Cell Neurosci; 2022; 16():1057857. PubMed ID: 36568890
[TBL] [Abstract][Full Text] [Related]
45. Retinoic acid administration normalizes aberrant microglial activation via regulating TREM2 transcription in the PFC of valproic acid induced autism rat.
Luo L; Li T; Wu Q; Yuan B; Hu C; Yang T; Wei H; Chen J
Neurosci Lett; 2023 Apr; 803():137193. PubMed ID: 36924930
[TBL] [Abstract][Full Text] [Related]
46. Reduced prefrontal dopaminergic activity in valproic acid-treated mouse autism model.
Hara Y; Takuma K; Takano E; Katashiba K; Taruta A; Higashino K; Hashimoto H; Ago Y; Matsuda T
Behav Brain Res; 2015 Aug; 289():39-47. PubMed ID: 25907743
[TBL] [Abstract][Full Text] [Related]
47. Increased GABAA receptor binding in amygdala after prenatal administration of valproic acid to rats.
Bertelsen F; Møller A; Folloni D; Drasbek KR; Scheel-Krüger J; Landau AM
Acta Neuropsychiatr; 2017 Oct; 29(5):309-314. PubMed ID: 27938419
[TBL] [Abstract][Full Text] [Related]
48. Emerging mechanisms of valproic acid-induced neurotoxic events in autism and its implications for pharmacological treatment.
Taleb A; Lin W; Xu X; Zhang G; Zhou QG; Naveed M; Meng F; Fukunaga K; Han F
Biomed Pharmacother; 2021 May; 137():111322. PubMed ID: 33761592
[TBL] [Abstract][Full Text] [Related]
49. Sex Differences in the Effects of Prenatal Bisphenol A Exposure on Genes Associated with Autism Spectrum Disorder in the Hippocampus.
Thongkorn S; Kanlayaprasit S; Jindatip D; Tencomnao T; Hu VW; Sarachana T
Sci Rep; 2019 Feb; 9(1):3038. PubMed ID: 30816183
[TBL] [Abstract][Full Text] [Related]
50. The valproic acid-induced rodent model of autism.
Nicolini C; Fahnestock M
Exp Neurol; 2018 Jan; 299(Pt A):217-227. PubMed ID: 28472621
[TBL] [Abstract][Full Text] [Related]
51. The Notch signaling pathway inhibitor Dapt alleviates autism-like behavior, autophagy and dendritic spine density abnormalities in a valproic acid-induced animal model of autism.
Zhang Y; Xiang Z; Jia Y; He X; Wang L; Cui W
Prog Neuropsychopharmacol Biol Psychiatry; 2019 Aug; 94():109644. PubMed ID: 31075347
[TBL] [Abstract][Full Text] [Related]
52. Human forebrain organoids reveal connections between valproic acid exposure and autism risk.
Meng Q; Zhang W; Wang X; Jiao C; Xu S; Liu C; Tang B; Chen C
Transl Psychiatry; 2022 Mar; 12(1):130. PubMed ID: 35351869
[TBL] [Abstract][Full Text] [Related]
53. Valproic acid induces aberrant development of striatal compartments and corticostriatal pathways in a mouse model of autism spectrum disorder.
Kuo HY; Liu FC
FASEB J; 2017 Oct; 31(10):4458-4471. PubMed ID: 28687613
[TBL] [Abstract][Full Text] [Related]
54. Sex-specific effects of prenatal valproic acid exposure on sociability and neuroinflammation: Relevance for susceptibility and resilience in autism.
Kazlauskas N; Seiffe A; Campolongo M; Zappala C; Depino AM
Psychoneuroendocrinology; 2019 Dec; 110():104441. PubMed ID: 31541913
[TBL] [Abstract][Full Text] [Related]
55. Functional and molecular characterization of a non-human primate model of autism spectrum disorder shows similarity with the human disease.
Watanabe S; Kurotani T; Oga T; Noguchi J; Isoda R; Nakagami A; Sakai K; Nakagaki K; Sumida K; Hoshino K; Saito K; Miyawaki I; Sekiguchi M; Wada K; Minamimoto T; Ichinohe N
Nat Commun; 2021 Sep; 12(1):5388. PubMed ID: 34526497
[TBL] [Abstract][Full Text] [Related]
56. Impaired repair of DNA damage is associated with autistic-like traits in rats prenatally exposed to valproic acid.
Servadio M; Manduca A; Melancia F; Leboffe L; Schiavi S; Campolongo P; Palmery M; Ascenzi P; di Masi A; Trezza V
Eur Neuropsychopharmacol; 2018 Jan; 28(1):85-96. PubMed ID: 29174949
[TBL] [Abstract][Full Text] [Related]
57. PI3K/AKT/mTOR-mediated autophagy in the development of autism spectrum disorder.
Zhang J; Zhang JX; Zhang QL
Brain Res Bull; 2016 Jul; 125():152-8. PubMed ID: 27320472
[TBL] [Abstract][Full Text] [Related]
58. Sex-biased single-cell genetic landscape in mice with autism spectrum disorder.
Zhang Q; Wang Y; Tao J; Xia R; Zhang Y; Liu Z; Cheng J
J Genet Genomics; 2024 Mar; 51(3):338-351. PubMed ID: 37703921
[TBL] [Abstract][Full Text] [Related]
59. Perinatal Influences of Valproate on Brain and Behaviour: An Animal Model for Autism.
Ranger P; Ellenbroek BA
Curr Top Behav Neurosci; 2016; 29():363-386. PubMed ID: 26510739
[TBL] [Abstract][Full Text] [Related]
60. Dendritic spine anomalies and PTEN alterations in a mouse model of VPA-induced autism spectrum disorder.
Mahmood U; Ahn S; Yang EJ; Choi M; Kim H; Regan P; Cho K; Kim HS
Pharmacol Res; 2018 Feb; 128():110-121. PubMed ID: 28823725
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
